Immunacia’s ViroStatics Reports Phase II Data on VS411, an AV-HALT for Treating HIV/AIDS, During the XVIII International AIDS Conference
7/19/2010 9:43:17 AM
More...
|
ViroStatics and Vichem Chemie Announce Strategic Partnership to Identify and Develop Kinase Inhibitors for the Treatment of HIV/AIDS and Other Chronic Diseases
6/11/2010 10:49:15 AM
More...
|
Dr. James Chafouleas Joins ViroStatics and Genetic Immunity as Strategic Adviser
5/3/2010 3:17:56 PM
More...
|
ViroStatics' Dr. Franco Lori to Present During 2009 Biotechnology Industry Organization (BIO) International Convention in Atlanta
5/18/2009 11:02:50 AM
More...
|
ViroStatics Acquires Library of Anti-Cancer/Antiviral Compounds From the University of Siena
4/14/2009 11:58:46 AM
More...
|